Evaluating only Nant Health’s profile at its peak — without knowing the outcome — the model ranked Unit economics as the #1 likely cause. Documented cause: Product failure.
Key Events Timeline
FOUNDING
Patrick Soon-Shiong founded Nant Health to build an AI-driven cancer genomics and hospital management platform.
FUNDING
IPO raised $115M on NASDAQ at $14/share, valuing the company at $2.5B despite minimal revenue.
LAYOFF
Multiple hospital systems canceled contracts citing poor EHR integration; stock fell below $3; mass layoffs began.
SHUTDOWN
Stock delisted from major indices, trading below $0.50; operations effectively ceased as core product was abandoned.
Full Analysis
Free · no account needed
Documented cause
Nant Health, founded by billionaire Patrick Soon-Shiong, raised over $400M and went public in 2016 at a $2.5B valuation, promising AI-driven clinical decision support via its GPS Cancer platform. Revenue never exceeded $70M annually while losses mounted past $200M/year. By 2022, the stock had collapsed 97% from its IPO price and its primary hospital software customers had largely abandoned the platform due to poor integration and unfulfilled promises.
Lesson
“Celebrity founder funding cannot substitute for product-market fit, especially in clinical AI with long sales cycles.”